Drug Landscape ›
PROCYCLIDINE HYDROCHLORIDE ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 1,664
Most-reported reactions
Vomiting — 235 reports (14.12%) Schizophrenia — 210 reports (12.62%) Pneumonia — 197 reports (11.84%) Nausea — 191 reports (11.48%) Cholelithiasis — 178 reports (10.7%) Psychotic Disorder — 168 reports (10.1%) Condition Aggravated — 130 reports (7.81%) Hypomania — 121 reports (7.27%) Hepatic Enzyme Increased — 117 reports (7.03%) Hepatotoxicity — 117 reports (7.03%)
Source database →
PROCYCLIDINE HYDROCHLORIDE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is PROCYCLIDINE HYDROCHLORIDE approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for PROCYCLIDINE HYDROCHLORIDE in United States?
Marketing authorisation holder not available in our data.